4//SEC Filing
Troendle August J. 4
Accession 0001622058-25-000013
CIK 0001668397other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 4:14 PM ET
Size
8.1 KB
Accession
0001622058-25-000013
Insider Transaction Report
Form 4
Troendle August J.
DirectorCEO10% Owner
Transactions
- Sale
Common Stock
2025-11-18$590.84/sh−7,191$4,248,730→ 886,177 total - Sale
Common Stock
2025-11-19$592.07/sh−23,862$14,127,974→ 862,315 total
Holdings
- 4,733,019(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
- [F2]The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $590.00 to $592.09. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
- [F3]The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $590.00 to $594.065. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
- [F4]The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Documents
Issuer
Medpace Holdings, Inc.
CIK 0001668397
Entity typeother
Related Parties
1- filerCIK 0001622058
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 4:14 PM ET
- Size
- 8.1 KB